Dakota Wealth Management’s Apexigen, Inc. Common Stock APGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,950
Closed -$111K 624
2022
Q2
$111K Hold
10,950
0.01% 483
2022
Q1
$110K Hold
10,950
0.01% 440
2021
Q4
$110K Buy
+10,950
New +$109K 0.01% 378

Other funds holding APGN

Dakota Wealth Management's APGN Position: Q3 2022 in Review

Dakota Wealth Management sold out of Apexigen, Inc. Common Stock (APGN) in Q3 2022, closing a stake of 10,950 shares — an estimated $111K sold.

Dakota Wealth Management first reported a position in APGN in Q4 2021 and held it in 3 quarters. The position peaked at $111K in Q2 2022. 18 funds tracked by Wall St. Rank hold APGN as of Q3 2022.

  • Dakota Wealth Management reported no remaining Apexigen, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Dakota Wealth Management sold 10,950 Apexigen, Inc. Common Stock shares in Q3 2022, an estimated $111K.
  • Dakota Wealth Management first reported a position in Apexigen, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Dakota Wealth Management's Apexigen, Inc. Common Stock position peaked at $111K in Q2 2022.
  • 18 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q3 2022.

Based on Dakota Wealth Management's 13F filing for Q3 2022, filed 10 Nov 2022.